CEACAMP8

Across TCGA pan-cancer cohorts, CEACAMP8 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated CEACAMP8 data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher CEACAMP8 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CEACAMP8 expression acts as an unfavorable survival marker.

TGCT, UCEC, and KICH are the cancer types where CEACAMP8 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	108	view →
UCEC	OS	Tertile	All	0.687	0.881	<.001	108	view →
KICH	DFS	Tertile	All	0.624	0.937	.001	102	view →
KIRC	DFS	Tertile	All	0.219	0.638	.001	54	view →
HNSC	DFS	Tertile	IV	0.354	0.589	.007	18	view →
OV	DFS	Tertile	III,IV	0.366	0.540	.016	18	view →
PRAD	DFS	Tertile	All	0.742	0.937	.006	18	view →
THCA	DFS	Tertile	All	0.855	0.950	.014	15	view →
SKCM	DFS	Tertile	II,III,IV	0.206	0.602	.008	12	view →
LUSC	OS	Tertile	III,IV	0.147	0.416	.043	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

CEACAMP8–TGCT (OS)

Open the TGCT breakdown →